Sugi Predict

Sugi Predict / Compounds / SCHEMBL1785534

SCHEMBL1785534

SCHEMBL1785534

CC(C(=O)O)N1CCCCN(C(C)C(=O)O)CCN(C(C)C(=O)O)CCN(C(C)C(=O)O)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ DPP7 Q9UHL4 1/20 0.41
▸ ATM Q13315 2/20 0.41
▸ MAOB P27338 1/20 0.41
▸ CHRNB2 P17787 5/20 0.40
▸ SLC6A2 P23975 5/20 0.40
▸ CHRNB4 P30926 5/20 0.40
▸ CHRNA3 P32297 5/20 0.40
▸ CHRNA4 P43681 5/20 0.40
▸ SLC6A3 Q01959 5/20 0.40
▸ CHRNA1 P02708 4/20 0.40
▸ CHRNG P07510 4/20 0.40
▸ CHRNB1 P11230 4/20 0.40
▸ CHRND Q07001 4/20 0.40
▸ LMNA P02545 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ GAA P10253 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4939151 0.97 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ADPP7ATM
SCHEMBL30678696 0.97 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ADPP7ATM
SCHEMBL500405 0.97 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ADPP7ATM
SCHEMBL94069 0.95 DPP7 (0.45) ALDH1A1MEN1KMT2ADPP7ATM
Hydrochloric Acid SCHEMBL28356462 0.95 LMNA (0.44) ALDH1A1MEN1KMT2ADPP7ATM
SCHEMBL2792423 0.95 DPP7 (0.45) ALDH1A1MEN1KMT2ADPP7ATM
SCHEMBL10939615 0.95 DPP7 (0.45) ALDH1A1MEN1KMT2ADPP7ATM
SCHEMBL4938808 0.95 DPP7 (0.45) ALDH1A1MEN1KMT2ADPP7ATM
SCHEMBL14511367 0.95 KDM4E (0.39) ALDH1A1MEN1KMT2ADPP7ATM
SCHEMBL7539880 0.95 KDM4E (0.39) ALDH1A1MEN1KMT2ADPP7ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110206650-A1 Probiotic Formulations BRACCO IMAGING S.P.A. (IT) 2011-08-25 — — US claimed
EP-2206506-A1 Probiotic formulations Bracco Imaging S.p.A (IT) 2010-07-14 — — EP claimed
US-11905323-B2 Recombinant chimeric protein for selectins targeting Bracco Suisse (CH) 2024-02-20 — — US disclosed
WO-2023245100-A1 ANTIMICROBIAL NCR13 VARIANT PEPTIDES Vestaron Corporation (US) 2023-12-21 — — WO disclosed
US-20220389080-A1 RECOMBINANT CHIMERIC PROTEIN FOR SELECTINS TARGETING BRACCO SUISSE SA (CH) 2022-12-08 — — US disclosed
US-11370826-B2 Recombinant chimeric protein for selectins targeting BRACCO SUISSE SA (CH) 2022-06-28 — — US disclosed
EP-2320954-B1 DIAGNOSTIC AGENTS SELECTIVE AGAINST METALLOPROTEASES BRACCO IMAGING SPA (IT) 2019-09-04 — — EP disclosed
US-20190048062-A1 A RECOMBINANT CHIMERIC PROTEIN FOR SELECTINS TARGETING BRACCO SUISSE SA (CH) 2019-02-14 — — US disclosed
EP-3414261-A1 A RECOMBINANT CHIMERIC PROTEIN FOR SELECTINS TARGETING Bracco Suisse SA (CH) 2018-12-19 — — EP disclosed
WO-2017137477-A1 A RECOMBINANT CHIMERIC PROTEIN FOR SELECTINS TARGETING BRACCO SUISSE SA (CH) 2017-08-17 — — WO disclosed
US-9480758-B2 Diagnostic agents selective against metalloproteases BRACCO IMAGING S.P.A. (IT) 2016-11-01 — — US disclosed
EP-2206506-A1 Probiotic formulations Bracco Imaging S.p.A (IT) 2010-07-14 — — EP disclosed
US-20100166656-A1 Diagnostic And Radiotherapeutic Contrast Agents And Process For Their Preparation BRACCO IMAGING S.P.A. (IT) 2010-07-01 — — US disclosed
US-20100158814-A1 Fibrin-Binding Peptides and Conjugates Thereof BRACCO IMAGING S.P.A. (IT) 2010-06-24 — — US disclosed
WO-2010010079-A1 DIAGNOSTIC AGENTS SELECTIVE AGAINST METALLOPROTEASES BRACCO IMAGING SPA (IT) 2010-01-28 — — WO disclosed
EP-2147684-A1 Diagnostic Agents Selective Against Metalloproteases Bracco Imaging S.p.A (IT) 2010-01-27 — — EP disclosed
EP-2097438-A1 FIBRIN BINDING PEPTIDE CONJUGATES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS. Bracco Imaging S.p.A (IT) 2009-09-09 — — EP disclosed
WO-2008071679-A9 FIBRIN BINDING PEPTIDE CONJUGATES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS. BRACCO IMAGING SPA (IT) 2009-01-15 — — WO disclosed
EP-1964846-A1 Process for the preparation of contrast agents Bracco Imaging, S.P.A. (IT) 2008-09-03 — — EP disclosed
WO-2008071679-A1 FIBRIN BINDING PEPTIDE CONJUGATES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS. BRACCO IMAGING SPA (IT) 2008-06-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11905323-B2 Recombinant chimeric protein for selectins targeting SELPLG, SELL, SELE ALDH1A1 2114/4885MEN1 4580/4885KMT2A 4524/4885
US-20220389080-A1 RECOMBINANT CHIMERIC PROTEIN FOR SELECTINS TARGETING SELPLG, SELL, SELE ALDH1A1 2114/4885MEN1 4580/4885KMT2A 4524/4885
US-20190048062-A1 A RECOMBINANT CHIMERIC PROTEIN FOR SELECTINS TARGETING SELPLG, SELL, SELE ALDH1A1 1989/4885MEN1 4597/4885KMT2A 4420/4885
US-20100166656-A1 Diagnostic And Radiotherapeutic Contrast Agents And Process For Their Preparation LGALS1, LGALS3BP, C1QBP ALDH1A1 1950/4885MEN1 516/4885KMT2A 4295/4885
US-20100158814-A1 Fibrin-Binding Peptides and Conjugates Thereof FGB, F13B, F13A1 ALDH1A1 4790/4885MEN1 669/4885KMT2A 4486/4885
US-11370826-B2 Recombinant chimeric protein for selectins targeting SELPLG, SELL, SELE ALDH1A1 2114/4885MEN1 4580/4885KMT2A 4524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.